Common use of IPO Litigation Clause in Contracts

IPO Litigation. With respect to the litigation against the Company and certain of its directors and officers in the matter pending in the U.S. District Court for the Southern District of New York captioned In re Eloquent, Inc. Initial Public Offering Securities Litigation, Case No. 01-CV-6775; the claims, cross-claims, counterclaims or defenses that have been or are in the future asserted therein or that are related thereto or arise therefrom and the D&O Policies (as defined below) (collectively, the "IPO Litigation"), (a) All written documents provided by the Company or its agents to Acquiror or its Affiliates concerning the IPO Litigation, a list of which is included in Section 3.11 of the Company Letter, are true, correct, complete and, to the Knowledge of the Company, fairly present the status of the matters described in such written documents as of the respective dates of such documents. To the Knowledge of the Company, as of the date of this Agreement, there are no other written documents to which the Company has access containing additional material information regarding the IPO Litigation. (b) The Company has timely paid any and all payments required under the insurance policies identified in Section 3.11(b) of the Company Letter (the "D&O Policies"), each such policy is in full force and effect as of the date of this Agreement and there are no actual or contemplated events, including this Agreement and the transactions contemplated hereby, that will alter, limit, reduce or otherwise affect the coverage provided by those policies. Except for the IPO Litigation, neither the Company nor any director or officer has made any claim under the D&O Policies and to the Knowledge of the Company, no other event has occurred that would reduce the coverage limits available under the D&O Policies. The Company has taken all actions necessary, appropriate or advisable to maintain the applicability of the D&O Policies to the IPO Litigation and to tender under the D&O Policies all potentially insurable claims and costs related to the IPO Litigation. The Company has taken no action, nor has it refrained from action, such that any condition or term of the D&O Policies may have been violated or breached, resulting in any right of denial or reduction in insurance coverage for the IPO Litigation. The Company has taken all necessary actions to report the status of the IPO Litigation under the D&O Policies. (c) To the Knowledge of the Company, there are no facts, events or circumstances that could give rise to coverage exclusions or other coverage limitations under any of the D&O Policies, including without limitation exclusions related to intentional acts or illegal remuneration by the directors, officers and agents of Company and no coverage limitations or exclusions have been asserted by any insurer in connection with the IPO Litigation. The insurer providing primary coverage among the D&O Policies has not denied its duty to defend the Company in the IPO Litigation and none of the insurers issuing the D&O Policies has posited any limitation or exclusion in connection with such duty. (d) The retention on the D&O Policies equals Two Hundred Fifty-Thousand Dollars ($250,000), applicable to defense costs, of which approximately Seventy-Four Thousand Seven Hundred Thirty-Nine Dollars and Fifty-Four Cents ($74,739.54) had been invoiced as of November 30, 2002. The Company will inform Acquiror promptly after receipt of any other invoices of amounts applicable to the retention. A summary supporting the costs associated with the payment of the retention by the Company through July 25, 2002 has been forwarded to the D&O Policy carriers and such costs have not been rejected by the D&O Policy carriers. The Company will submit an updated summary of such costs within 30 days after the execution of this Agreement. The primary D&O Policy carrier has agreed to defense counsel selected by the Company.

Appears in 2 contracts

Samples: Merger Agreement (Reid Clifford A), Merger Agreement (Eloquent Inc)

AutoNDA by SimpleDocs

IPO Litigation. With respect Following the Closing, SPX agrees to indemnify, defend and hold harmless (but only to the litigation extent set forth below) the Company from any Judgments (as hereinafter defined) entered against the Company in, or amounts paid by the Company in settlement of, the IPO Litigation (as hereinafter defined) and certain of its directors any Defense Costs (as hereinafter defined) incurred by the Company from and officers in after the matter pending in Closing for which the U.S. District Court for the Southern District of New York captioned In re Eloquent, Inc. Initial Public Offering Securities Litigation, Case No. 01-CV-6775; the claims, cross-claims, counterclaims or defenses that insurers would have been or are in required to reimburse the future asserted therein or that are related thereto or arise therefrom and Company under the D&O terms of the Policies (as defined belowhereinafter defined) ("IPO Amounts"); provided, however, that SPX shall only be liable under this Section 5.12 if and to the extent a Judgment has been entered that the applicable SPX insurance policy or policies (collectively, the "Policies") do not insure against the IPO Litigation"), (a) All written documents provided Amounts. SPX's liability under this Section 5.12 shall be limited to the amount that would have been payable by the Company or its agents to Acquiror or its Affiliates concerning insurers under the Policies had there been no Judgment entered that the Policies do not insure against the IPO LitigationAmounts, a list and shall therefore be reduced by all amounts that would have reduced the amount of which is included in Section 3.11 recovery under the terms of the Company LetterPolicies had coverage been in effect, are trueincluding the amount of any deductible, correct, complete and, to self-retention or co-payment and any reduction in the Knowledge amount of coverage as a result of the Company, fairly present the status of the matters described in such written documents as of the respective dates of such documents. To the Knowledge of the Company, as of the date of this Agreement, there are no insurer having to pay other written documents to which the Company has access containing additional material information regarding the IPO Litigation. (b) The Company has timely paid any and all payments required claims under the insurance policies identified in Section 3.11(b) of the Company Letter (the "D&O Policies"), each such policy is in full force and effect as of the date of this Agreement and there are no actual or contemplated events, including this Agreement and the transactions contemplated hereby, that will alter, limit, reduce or otherwise affect the coverage provided by those policies. Except for the IPO Litigation, neither the Company nor any director or officer has made any claim under the D&O Policies and to the Knowledge of the Company, no other event has occurred that would reduce the coverage limits available under the D&O Policies. The Company has taken all actions necessary, appropriate or advisable to maintain the applicability of the D&O Policies to SPX shall vigorously defend the IPO Litigation and to tender under shall control the D&O Policies all potentially insurable claims and costs related to the IPO Litigation. The Company has taken no action, nor has it refrained from action, such that any condition or term of the D&O Policies may have been violated or breached, resulting in any right of denial or reduction in insurance coverage for the IPO Litigation. The Company has taken all necessary actions to report the status defense of the IPO Litigation under including any settlement thereof. CNT agrees to, and to cause the D&O Policies. (c) To Company to, cooperate with SPX in the Knowledge defense and settlement of the IPO Litigation including providing SPX with access to books and records and personnel of the Company. Following the Closing, there are no facts, events or circumstances that could give rise to coverage exclusions or other coverage limitations under any of the D&O Policies, including without limitation exclusions related to intentional acts or illegal remuneration by the directors, officers and agents of Company and no coverage limitations or exclusions have been asserted by any insurer in connection with the IPO Litigation. The insurer providing primary coverage among the D&O Policies has not denied its duty to defend the Company in the IPO Litigation and none of the insurers issuing the D&O Policies has posited any limitation or exclusion in connection with such duty. (d) The retention on the D&O Policies equals Two Hundred Fifty-Thousand Dollars ($250,000), applicable to defense costs, of which approximately Seventy-Four Thousand Seven Hundred Thirty-Nine Dollars and Fifty-Four Cents ($74,739.54) had been invoiced as of November 30, 2002. The Company will inform Acquiror promptly after receipt of any other invoices of amounts applicable to the retention. A summary supporting the costs associated with the payment of the retention by the Company through July 25, 2002 has been forwarded to the D&O Policy carriers and such costs have not been rejected by the D&O Policy carriers. The Company will submit an updated summary of such costs within 30 days after the execution of this Agreement. The primary D&O Policy carrier has agreed to defense counsel selected by the Company.CNT shall cause the

Appears in 2 contracts

Samples: Merger Agreement (Computer Network Technology Corp), Merger Agreement (Computer Network Technology Corp)

AutoNDA by SimpleDocs

IPO Litigation. With respect Following the Closing, SPX agrees to indemnify, defend and hold harmless (but only to the litigation extent set forth below) the Company from any Judgments (as hereinafter defined) entered against the Company in, or amounts paid by the Company in settlement of, the IPO Litigation (as hereinafter defined) and certain of its directors any Defense Costs (as hereinafter defined) incurred by the Company from and officers in after the matter pending in Closing for which the U.S. District Court for the Southern District of New York captioned In re Eloquent, Inc. Initial Public Offering Securities Litigation, Case No. 01-CV-6775; the claims, cross-claims, counterclaims or defenses that insurers would have been or are in required to reimburse the future asserted therein or that are related thereto or arise therefrom and Company under the D&O terms of the Policies (as defined belowhereinafter defined) ("IPO Amounts"); provided, however, that SPX shall only be liable under this Section 5.12 if and to the extent a Judgment has been entered that the applicable SPX insurance policy or policies (collectively, the "Policies") do not insure against the IPO Litigation"), (a) All written documents provided Amounts. SPX's liability under this Section 5.12 shall be limited to the amount that would have been payable by the Company or its agents to Acquiror or its Affiliates concerning insurers under the Policies had there been no Judgment entered that the Policies do not insure against the IPO LitigationAmounts, a list and shall therefore be reduced by all amounts that would have reduced the amount of which is included in Section 3.11 recovery under the terms of the Company LetterPolicies had coverage been in effect, are trueincluding the amount of any deductible, correct, complete and, to self-retention or co-payment and any reduction in the Knowledge amount of coverage as a result of the Company, fairly present the status of the matters described in such written documents as of the respective dates of such documents. To the Knowledge of the Company, as of the date of this Agreement, there are no insurer having to pay other written documents to which the Company has access containing additional material information regarding the IPO Litigation. (b) The Company has timely paid any and all payments required claims under the insurance policies identified in Section 3.11(b) of the Company Letter (the "D&O Policies"), each such policy is in full force and effect as of the date of this Agreement and there are no actual or contemplated events, including this Agreement and the transactions contemplated hereby, that will alter, limit, reduce or otherwise affect the coverage provided by those policies. Except for the IPO Litigation, neither the Company nor any director or officer has made any claim under the D&O Policies and to the Knowledge of the Company, no other event has occurred that would reduce the coverage limits available under the D&O Policies. The Company has taken all actions necessary, appropriate or advisable to maintain the applicability of the D&O Policies to SPX shall vigorously defend the IPO Litigation and to tender under shall control the D&O Policies all potentially insurable claims and costs related to the IPO Litigation. The Company has taken no action, nor has it refrained from action, such that any condition or term of the D&O Policies may have been violated or breached, resulting in any right of denial or reduction in insurance coverage for the IPO Litigation. The Company has taken all necessary actions to report the status defense of the IPO Litigation under including any settlement thereof. CNT agrees to, and to cause the D&O Policies. (c) To Company to, cooperate with SPX in the Knowledge defense and settlement of the IPO Litigation including providing SPX with access to books and records and personnel of the Company. Following the Closing, there are no facts, events or circumstances that could give rise to coverage exclusions or other coverage limitations under any of CNT shall cause the D&O Policies, including without limitation exclusions related to intentional acts or illegal remuneration by the directors, officers and agents of Company and no coverage limitations or exclusions have been asserted by any insurer in connection with the IPO Litigation. The insurer providing primary coverage among the D&O Policies has not denied its duty to defend the Company in the IPO Litigation and none of the insurers issuing the D&O Policies has posited any limitation or exclusion in connection with such duty. (d) The retention on the D&O Policies equals Two Hundred Fifty- 26 -Thousand Dollars ($250,000), applicable to defense costs, of which approximately Seventy-Four Thousand Seven Hundred Thirty-Nine Dollars and Fifty-Four Cents ($74,739.54) had been invoiced as of November 30, 2002. The Company will inform Acquiror promptly after receipt of any other invoices of amounts applicable to the retention. A summary supporting the costs associated with the payment of the retention by the Company through July 25, 2002 has been forwarded to the D&O Policy carriers and such costs have not been rejected by the D&O Policy carriers. The Company will submit an updated summary of such costs within 30 days after the execution of this Agreement. The primary D&O Policy carrier has agreed to defense counsel selected by the Company.

Appears in 1 contract

Samples: Merger Agreement (Inrange Technologies Corp)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!